We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Malfunctioning Tumor Suppressor Genes Spur Growth of Liver Cancer

By LabMedica International staff writers
Posted on 24 Nov 2008
Cancer researchers have combined genomics, RNA interference, and mosaic mouse models to track down and identify a group of tumor suppressor genes that fails to operate in liver cancer cells.

Investigators at Cold Spring Harbor Laboratory (NY, USA) began by compiling pools of short hairpin RNAs (shRNAs) that specifically blocked the activity of the mouse orthologs of genes recurrently deleted in a series of human liver cancers. More...
Assuming that some of these shRNAs would inhibit tumor-suppressing genes, they tested the ability of the shRNAs to promote tumorigenesis in a mosaic mouse model.

They reported in the November 13, 2008, issue of the journal Cell that they had identified and validated 13 tumor suppressor genes, 12 of which had not been linked to cancer before. One gene, XPO4, encoded a nuclear export protein whose substrate, EIF5A2, was amplified in human tumors, was required for proliferation of XPO4-deficient tumor cells, and promoted liver cancer in mice.

"Apparently, there is a high incidence of cancer genes that are physically next to each other in the genome,” explained senior author Dr. Scott Lowe, professor of cellular and molecular biology at Cold Spring Harbor Laboratory. "It may explain why cancer is so heterogeneous; there are a lot of possible combinations to get there. It is important to understand all the genetic alterations that can give rise to cancer. If we understand cancer, we can treat it better by going after the molecular causes or by categorizing cancers to better predict their behavior.”

Related Links:
Cold Spring Harbor Laboratory



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.